Botanix Pharmaceuticals (BOT) has had its application to use the novel sofpironium bromide gel to treat primary axillary hyperhidrosis rejected by the US Food and Drug Administration (FDA).Source:
https://themarketherald.com.au/botanix-pharmaceuticals-asxbot-suffers-setback-in-fda-approval-for-sofpironium-bromide-gel-to-treat-hyperhidrosis-2023-09-26/
there is no guarantee that by mid 2024 it will be given the approval and it may well get rejected again if the management stuffs up again .
It is up to people what they choose to believe.
Many will always tell you to BUY
Some will always tell you to SELL
but then we have a very few who will do both as per what the market and the smart money is telling them.
Make your investment decisions wisely and always DYOR.
Botanix Pharmaceuticals (BOT) has had its application to use the...
-
- There are more pages in this discussion • 5,382 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.005(1.56%) |
Mkt cap ! $567.9M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.0¢ | 31.0¢ | $1.258M | 3.998M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 650888 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 1176570 | 24 |
View Market Depth
| Last trade - 15.33pm 18/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |